DRW Securities’s Shuttle Pharmaceuticals SHPH Stock Holding History

DRW Securities’s Portfolio SHPH Stock Details SHPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,283	Closed	-$152K	–	1648
2025 Q3	$152K	Buy	+4,283	New	+$160K	﹤0.01%	1131

Other funds holding SHPH

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

DRW Securities's SHPH Position: Q4 2025 in Review

DRW Securities sold out of Shuttle Pharmaceuticals (SHPH) in Q4 2025, closing a stake of 4,283 shares — an estimated $152K sold.

DRW Securities first reported a position in SHPH in Q3 2025 and held it in 1 quarter. The position peaked at $152K in Q3 2025. 7 funds tracked by Wall St. Rank hold SHPH as of Q4 2025.

DRW Securities reported no remaining Shuttle Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
DRW Securities sold 4,283 Shuttle Pharmaceuticals shares in Q4 2025, an estimated $152K.
DRW Securities first reported a position in Shuttle Pharmaceuticals in Q3 2025 and held it in 1 quarter.
DRW Securities's Shuttle Pharmaceuticals position peaked at $152K in Q3 2025.
7 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q4 2025.

Based on DRW Securities's 13F filing for Q4 2025, filed 12 Feb 2026.